Tuesday, December 10, 2024 7:25:22 AM
I did read the JAMA journal and read what combo trials can do to survival.
Management is totally hopeless since they didn't manage to partner like +10 years ago.
I suspect it's their own greed that's the culprit, they likely wanted an unrealistic deal with BP, but they gave L.P. the cold shoulder.
Issuing millions of shares to themselves over the years is another, what on earth is this! Further watering out shareholder value!
It's none of your business why I am here, and I have the right to write what I want as long as I don't brake forums rules.
No, I didn't sell any shares because my trading platform have prohibited customers buying this OTC stock as of last year, but can keep what I have.
I am staying until MHRA do something, but they don't seem to be in a hurry.
I don't want to discuss AVXL here, but come over to that board if you want more info.
I think we are around 4-5 that have both stickers.
Management is totally hopeless since they didn't manage to partner like +10 years ago.
I suspect it's their own greed that's the culprit, they likely wanted an unrealistic deal with BP, but they gave L.P. the cold shoulder.
Issuing millions of shares to themselves over the years is another, what on earth is this! Further watering out shareholder value!
It's none of your business why I am here, and I have the right to write what I want as long as I don't brake forums rules.
No, I didn't sell any shares because my trading platform have prohibited customers buying this OTC stock as of last year, but can keep what I have.
I am staying until MHRA do something, but they don't seem to be in a hurry.
I don't want to discuss AVXL here, but come over to that board if you want more info.
I think we are around 4-5 that have both stickers.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
